During the past decade, Cancer Research UK Clinical Trials Unit - Birmingham conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Research UK Clinical Trials Unit - Birmingham" #1 sponsor was "Gustave Roussy, Cancer Campus, Grand Paris" with 2 trials, followed by "University Hospital Birmingham" with 2 trials sponsored, "Cancer Research Campaign Clinical Trials Centre" with 1 trials sponsored, "Cancer Research UK" with 1 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research UK Clinical Trials Unit - Birmingham" #1 collaborator was "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Research UK Clinical Trials Unit - Birmingham" are "Breast Cancer" (2 trials), "Liver Cancer" (2 trials), "Recurrent Low-grade Gliomas" (2 trials), "Refractory Low-grade Gliomas" (2 trials) and "Brain and Central Nervous System Tumors" (1 trials). Many other conditions were trialed in "Cancer Research UK Clinical Trials Unit - Birmingham" in a lesser frequency.

Most popular intervention types in "Cancer Research UK Clinical Trials Unit - Birmingham" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "Vinblastine" (2 trials), "Nilotinib" (1 trials), "Vinblastine + Nilotinib" (1 trials) and "biologic sample preservation procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research UK Clinical Trials Unit - Birmingham" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Research UK Clinical Trials Unit - Birmingham". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cancer Research UK Clinical Trials Unit - Birmingham, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research UK Clinical Trials Unit - Birmingham, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".